Hua Medicine Press Release


Hua Medicine Announces 2024 Annual Results
Mar 28, 2025 21:51 JST
Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results of the Company and its subsidiaries for the year ended December 31, 2024 (the "Reporting Period"), along with the Company's business progress in 2024 and future business outlook.
More info..

Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce
Mar 18, 2025 22:36 JST
On March 17th, the highly anticipated 7th Commendation and Exchange Conference for the Leading Figures in Shanghai's Industry and Commerce was brought to a successful conclusion. Dr. Li Chen, the founder and CEO of Hua Medicine, was awarded the title of "A Leading Figure in Shanghai's Industry and Commerce" for his outstanding contributions and innovative leadership in the field of biomedicine.
More info..

Latest Release


More Latest Release >>